Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo (Q39412061)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 January 2012

Language	Label	Description	Also known as
English	Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo	scientific article published on 9 January 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

author name string

Jing Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Jin-Shui Zhu

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Zhou Zhou

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Wei-Xiong Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Ni-Wei Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

9 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Oncology Reports

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1511-1519

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Expression of p-Akt and COX-2 in gastric adenocarcinomas and adenovirus mediated Akt1 and COX-2 ShRNA suppresses SGC-7901 gastric adenocarcinoma and U251 glioma cell growth in vitro and in vivo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Understanding the role of tissue degrading enzymes and their inhibitors in development and disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Amphoterin as an extracellular regulator of cell motility: from discovery to disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Inflammation and necrosis promote tumour growth

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Akt1/protein kinase B alpha is involved in gastric cancer progression and cell proliferation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

The expression of HMGB1 protein and its receptor RAGE in human malignant tumors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

The genetics of the p53 pathway, apoptosis and cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

AKT/PKB signaling: navigating downstream

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

The Akt/protein kinase B-dependent anti-apoptotic pathway and the mitogen-activated protein kinase cascade are alternatively activated in human glioblastoma multiforme

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Activation of gene expression in human neutrophils by high mobility group box 1 protein

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Ethyl pyruvate administration inhibits hepatic tumor growth

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Global cancer statistics, 2002

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

The role of high-mobility group box-1 in renal ischemia and reperfusion injury and the effect of ethyl pyruvate.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Tissue-specific expression profiling of receptor for advanced glycation end products and its soluble forms in esophageal and lung cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Ethyl pyruvate stabilizes hypoxia-inducible factor 1 alpha via stimulation of the TCA cycle

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

RNA interference targeting Akt promotes apoptosis in hypoxia-exposed human neuroblastoma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Inhibition by ethyl pyruvate of the nuclear translocation of nuclear factor-kappaB in cultured lung epithelial cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

High-mobility group box 1 and cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Akt/PKB activation in gastric carcinomas correlates with clinicopathologic variables and prognosis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Growth suppression and radiosensitivity increase by HMGB1 in breast cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

The mitochondrial p53 pathway

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/OR.2012.1623

Identifiers

10.3892/OR.2012.1623

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39412061&oldid=2043271985"